CVE-2010-0961

Description

Buffer overflow in qoslist in bos.net.tcp.server in IBM AIX 6.1 and VIOS 2.1 allows local users to gain privileges via unspecified vectors.

Category

7.2
CVSS
Severity: High
CVSS 2.0 •
EPSS 0.07%
Vendor Advisory ibm.com Vendor Advisory ibm.com Vendor Advisory ibm.com Vendor Advisory ibm.com Vendor Advisory vupen.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://aix.software.ibm.com/aix/efixes/security/qoslist_advisory.asc
http://securitytracker.com/id?1023694 vdb entry
http://www.vupen.com/english/advisories/2010/0556 vdb entry vendor advisory
http://www.ibm.com/support/docview.wss?uid=isg1IZ71590 vendor advisory
http://www.ibm.com/support/docview.wss?uid=isg1IZ71554 vendor advisory
http://www.ibm.com/support/docview.wss?uid=isg1IZ68194 vendor advisory
https://oval.cisecurity.org/repository/search/definition/oval%3Aorg.mitre.oval%3Adef%3A12051 vdb entry signature
http://www.ibm.com/support/docview.wss?uid=isg1IZ71869 vendor advisory

Frequently Asked Questions

What is the severity of CVE-2010-0961?
CVE-2010-0961 has been scored as a high severity vulnerability.
How to fix CVE-2010-0961?
To fix CVE-2010-0961, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2010-0961 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2010-0961 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.